Clinical trials
Terminated Phase 3 Lung Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| InterMune | 3 |
| Aeris Therapeutics | 1 |
| AstraZeneca | 1 |
| Daiichi Sankyo | 1 |
| Emory University | 1 |
| Hoffmann-La Roche | 1 |
| Immtech Pharmaceuticals, Inc | 1 |
| Lung Biotechnology PBC | 1 |
| Mannkind Corporation | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 17 |
| Respiratory Tract Diseases | 8 |
| Bronchial Diseases | 3 |
| Idiopathic Pulmonary Fibrosis | 3 |
| Pulmonary Fibrosis | 3 |
| Asthma | 2 |
| Bronchiectasis | 2 |
| Carcinoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Cystic Fibrosis | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.